Sight Diagnostics is a medical device company bringing affordable, accurate diagnostics to the point-of-care.
Sight Diagnostics has raised €110M across 3 funding rounds from 6 investors, most recently a Series D+ round in Jul 2020. Based in Tel Aviv, Israel; founded 2011; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-07-26 | Series D+ | €61M | Clal Biotechnology Industries | View deal → |
| 2019-01-01 | Series C | €24M | GO CAPITAL,Jack Nicklaus II,Longliv Ventures,New Alliance Capital,OurCrowd | View deal → |
| 2018-12-23 | Series C | €25M | — | View deal → |
